Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Superiority of Peroral Sodium Hyaluronate to Placebo in Improving the Skin Hydration

NCT07065110 is registered in ClinicalTrials.gov with Contipro Pharma a.s. as lead sponsor.

NCT NCT07065110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07065110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate the Superiority of Peroral Sodium Hyaluronate to Placebo in Improving the Skin Hydration
Lead sponsor
Contipro Pharma a.s.
Phase
Not applicable
Overall status
Completed
Start date
June 17, 2024
Completion date
December 13, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin conditions